UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.78 -0.85 (-1.03%) GOLD FUTURES
2,303.50 -54.20 (-2.30%) DOW
38,032.74 -353.35 (-0.92%) Bitcoin GBP
50,119.69 -539.11 (-1.06%)
Vanda Pharmaceuticals Inc. (VNDA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:37PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 277.33M |
| Enterprise value | -101.53M |
| Trailing P/E | 120.50 |
| Forward P/E | 30.30 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.44 |
| Price/book (mrq) | 0.51 |
| Enterprise value/revenue | -0.53 |
| Enterprise value/EBITDA | 9.28 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.78 |
| 52-week change 3 | -24.92% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 7.0000 |
| 52-week low 3 | 3.3000 |
| 50-day moving average 3 | 4.2890 |
| 200-day moving average 3 | 4.4661 |
Share statistics
| Avg vol (3-month) 3 | 2.36M |
| Avg vol (10-day) 3 | 3.86M |
| Shares outstanding 5 | 57.54M |
| Implied shares outstanding 6 | 57.54M |
| Float 8 | 52.05M |
| % held by insiders 1 | 5.21% |
| % held by institutions 1 | 89.45% |
| Shares short (15 Apr 2024) 4 | 2.07M |
| Short ratio (15 Apr 2024) 4 | 0.57 |
| Short % of float (15 Apr 2024) 4 | 4.53% |
| Short % of shares outstanding (15 Apr 2024) 4 | 3.60% |
| Shares short (prior month 15 Mar 2024) 4 | 3M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 1.30% |
| Operating margin (ttm) | -15.67% |
Management effectiveness
| Return on assets (ttm) | -1.36% |
| Return on equity (ttm) | 0.47% |
Income statement
| Revenue (ttm) | 192.64M |
| Revenue per share (ttm) | 3.36 |
| Quarterly revenue growth (yoy) | -29.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -10.94M |
| Net income avi to common (ttm) | 2.51M |
| Diluted EPS (ttm) | 0.0400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 388.26M |
| Total cash per share (mrq) | 6.75 |
| Total debt (mrq) | 9.4M |
| Total debt/equity (mrq) | 1.73% |
| Current ratio (mrq) | 4.94 |
| Book value per share (mrq) | 9.47 |
Cash flow statement
| Operating cash flow (ttm) | 12.8M |
| Levered free cash flow (ttm) | -88.78M |
© 2024 Yahoo. All rights reserved.